Abstract Title:

A randomized, prospective, placebo-controlled clinical trial of a novel zinc-monocysteine compound in age-related macular degeneration.

Abstract Source:

Curr Eye Res. 2008 Jul;33(7):591-8. PMID: 18600492

Abstract Author(s):

David A Newsome

Article Affiliation:

Retinal Institute of Louisiana, New Orleans, Louisiana, USA. [email protected]


PURPOSE: To test the hypothesis that daily use of zinc-monocysteine (ZMC) supplement will be well tolerated and result in improved macular function in persons with dry age-related macular degeneration (AMD). METHODS: Eligible, consenting subjects were randomized to either ZMC 25 mg or placebo twice daily for 6 months. Both ZMC and placebo groups enrolled 40 participants, with best corrected visual acuity 20/25 to 20/70, macular drusen, and pigment changes. Masked personnel determined baseline, 3- and 6-month best-corrected visual acuity, contrast sensitivity, and light flash recovery time. Differences between ZMC and placebo were analyzed by a one-sided unpaired t-test of the paired differences between baseline and 3- and 6-month timepoints for right and left eyes separately. RESULTS: By 6 months the ZMC group showed improved visual acuity (p<0.0001) and contrast sensitivity (p<0.0001). Macular light flash recovery time shortened in the ZMC group at 3 months by 2.1 sec (left eye, p = 0.0001) to 3.6 sec (right eye, p<0.0001), and at 6 months by 7.2 sec (left eye, p<0.0001) to 7.4 sec (right eye, p<0.0001). This variable had no improvement in the placebo group. ZMC had a gastrointestinal irritation rate of under 2%. CONCLUSION: ZMC 25 mg twice daily was well tolerated and was associated with improved macular function in comparison to a placebo in persons with dry AMD.

Study Type : Human Study

Print Options

Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.